flying bird

Tricks and Tips

Thursday, 2 May 2019

CORPORATE NEWS By CapitalStars 02/May/2019



Jet Airways plunges 17% on report of bidders fail to submit EoI
Shares of Jet Airways were trading 17% down on Thursday after an Economic Times report suggested that bidders of the debt-laden airline failed to submit their expression of interest.
As per the report, three of the four qualified bidders TGP Capital, Etihad Airways and Indigo failed to ink mandatory nondisclosure agreements for due diligence, with less than 10 days remaining for the final submission of bids.
National Investment and Infrastructure Fund (NIIF) has been looking into Jet accounts and key documents as part of the due diligence. The bidders have to submit their offer for the debt ridden airline till May 10.

Dabur's net profit drops 6% at Rs371.49cr in Q4FY19
Dabur India Limited, one of India's leading FMCG companies, reported a decline in net profit by 6% at Rs371.49cr during the quarter ended March 31, 2019, as compared to Rs397.18cr during the same period last year.
The company's revenue from operations during the quarter increased by 5% to Rs2,128.19cr compared to Rs2,032.91cr during the same quarter last year.
The exceptional item of Rs75.34cr for the quarter and year ended March 31, 2019, represents charge on account of impairment of goodwill in one of its wholly-owned subsidiary Hobi Kozmetic, Turkey in view of currency devaluation. This impairment pertains to consumer care segment business of the company.

Bandhan Bank's Q4FY19 Net Profit up by 67.78% to Rs651cr
Bandhan Bank's Net Profit for Q4FY19 increased by 67.78% to Rs651cr. The banks's Net lnterest Income (Nll) for the quarter grew by 45.60% at Rs1,258cr vs. Rs864cr in the corresponding quarter of the previous year.
The bank's Non-interest income grew by 91.13% at Rs388cr forthe quarter ended March 31,2019 against Rs203cr in the corresponding quarter of the previous year. Operating profit for the quarter increased by 63.92% at Rs1,154cr against Rs1,704cr in Q4FY18. Net Profit for the quarter grew by 67.78% at Rs651cr against Rs388cr in the corresponding quarter oft the previous year. Net Interest Margin (NlM) for the current quarter came in at 70.69% against 9.32% in the corresponding quarter of the previous year.

Natco Pharma receive USFDA approval for generic Bosentan Tablets
Natco Pharma Limited received the final approval of Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (USFDA) for Bosentan tablets in the strengths of 62.5 mg and 125 mg.
Bosentan is used for the treatment of patients with pulmonary arterial hypertension, the company said in the filing.
The tablets of Natco are marketed by its partner Lupin and are a generic version of Actelion Pharmaceuticals Ltd Tracleer tablets in the same strengths.

L&T Construction bags large orders across various business segments
In a major international competitive bidding process, the Metallurgical and Material Handling Business of L&T Construction has been awarded a Large order from MA'ADEN Gold and Base Metal Company (MGBM), wholly owned subsidiary of Saudi Arabia Mining Company (MA'ADEN) for setting up Mansourah Massarrah Gold project. Ma'aden is the champion of the Saudi Arabian Mining Industry, and now internationally recognized mining company with global presence.
This (EPC) Engineering, Procurement & Construction order for Gold processing plant in the Kingdom of Saudi Arabia, secured against stiff global competition is the largest single EPC order for the Metallurgical business in International market.




Investment  trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
 
For more details call on 9977499927 or visit our website www.capitalstars.com

0 comments:

Post a Comment